Molecular mechanistic insights into the treatment of metastatic Breast cancer in post- menopausal women: Fulvestrant/Faslodex, a selective estrogen receptor down-regulator, suppresses the expression of Interleukin-2 via down regulation of its target gene, 17/April/2014, 7.17 am

Molecular mechanistic insights into the treatment of metastatic Breast cancer in post- menopausal women: Fulvestrant/Faslodex, a selective estrogen receptor down-regulator, increases the expression of pro-apoptotic protein Fas via down regulation of its target gene, 17/April/2014, 7.15 am
April 17, 2014
Molecular Mechanistic insights into the treatment of Myocardial hypertrophy: Genistein inhibits Angiotensin II-Induced myocardial hypertrophy via down regulation of ATG9A expression and autophagic activity, 17/April/2014, 7.55 am
April 17, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Molecular mechanistic insights into the treatment of metastatic Breast cancer in post- menopausal women: Fulvestrant/Faslodex, a selective estrogen receptor down-regulator, suppresses the expression of  Interleukin-2 via down regulation of its target gene, 17/April/2014, 7.17 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.